QMS Medical Allied Services Ltd
Ticker: QMSMEDI
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
103.60
Market Cap
200.34
Debt/Equity
0.5628
ROE %
13.017
PB
1.8706
Promoter %
68.067
Pledge %
0.000
1Y Rev Growth %
28.665
5Y Rev Growth %
NP Margin %
7.659
NP Margin 5Y Avg %
Trading Reference
1M Return %
11.701
6M Return %
0.183
1Y Return %
-12.455
% Away 52W High
17.853
% Away 52W Low
44.840
Daily Volume
18000
Investment Verdict
Buy
Score 87/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 43/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
QMS Medical Allied Services Ltd is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend if it breaks above recent resistance. Volume has been increasing, suggesting growing interest, which could lead to a bullish scenario in the medium term.
Upside Probability: 25% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
E
Enser Communications Ltd
Enser Communications Ltd shows potential in a growing sector but faces significant risks and inconsistencies in financial performance.
View details
S
SBEC Sugar Ltd
SBEC Sugar Ltd shows potential in a vital sector but faces challenges in growth consistency and market execution.
View details
C
Cressanda Railway Solutions Ltd
Cressanda Railway Solutions Ltd presents several risks with inconsistent growth and profitability metrics. The valuation appears stretched compared to peers, and governance issues may raise concerns for investors.
View details
A
Arvee Laboratories (India) Ltd
Arvee Laboratories presents several risks with inconsistent growth and average profitability metrics, making it a risky investment at this time.
View details
D
Ducon Infratechnologies Ltd
Ducon Infratechnologies Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in performance metrics.
View details
R
Ruchi Infrastructure Ltd
Ruchi Infrastructure Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
S
Shri Techtex Ltd
Shri Techtex Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside concerns in governance and market sentiment.
View details
T
TBI Corn Ltd
TBI Corn Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
K
Kanchi Karpooram Ltd
Kanchi Karpooram Ltd presents a risky investment opportunity due to inconsistent growth and average profitability metrics, with concerns over valuation and market sentiment.
View details
R
Readymix Construction Machinery Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
P
PRO FX Tech Ltd
PRO FX Tech Ltd shows potential but faces challenges in growth consistency and market competition.
View details
S
Sumuka Agro Industries Ltd
Sumuka Agro Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Mangalam Industrial Finance Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
K
Kimia Biosciences Ltd
Kimia Biosciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
HCP Plastene Bulkpack Ltd
HCP Plastene Bulkpack Ltd shows potential for growth with a decent business model, but faces challenges in execution and valuation metrics.
View details
L
Lancor Holdings Ltd
Lancor Holdings Ltd presents a risky investment due to inconsistent growth and weak market sentiment.
View details
Business Overview
QMS Medical Allied Services Ltd is a leading provider of healthcare solutions in India, specializing in medical equipment and allied services. Catering to hospitals, clinics, and healthcare professionals, QMS is committed to enhancing patient care through innovative products and reliable service. With a focus on quality and compliance, the company plays a crucial role in the healthcare ecosystem, ensuring that medical facilities are equipped with the best tools available. Trust in QMS for dependable solutions that prioritize health and safety.
- Leading provider of healthcare solutions in India
- Specializes in medical equipment and allied services
- Serves hospitals, clinics, and healthcare professionals
- Focus on quality and compliance in all products
- Enhances patient care through innovative solutions
- Reliable partner in the healthcare ecosystem
Investment Thesis
QMS Medical Allied Services Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital healthcare services, and attractive valuation compared to industry peers. This combination positions the company for robust future performance.
- Strong promoter group with a proven track record in healthcare.
- Expanding digital services segment poised for growth in a tech-driven market.
- Attractive valuation metrics compared to peers, offering a margin of safety.
- Strategic partnerships enhancing service offerings and market reach.
- Resilience in the healthcare sector providing stability amid economic fluctuations.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare services
- Expansion into untapped markets
- Innovative product offerings
- Strong partnerships with hospitals
- Government support for healthcare sector
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in healthcare
- Dependence on key suppliers
- Economic downturn impacting spending
- Potential litigation issues
Peer Perspective
QMS Medical Allied Services Ltd trades at a 15% discount to peers like Dr. Lal PathLabs and Thyrocare, primarily due to margin concerns; a sustained improvement in profitability could trigger a rerating.
Future Outlook
QMS Medical Allied Services Ltd is well-positioned for growth, driven by innovative product developments and expanding market opportunities; however, successful execution and stringent cost control will be crucial to achieving these goals.
📊 Stock Investment Checklist (100 Points)
QMS Medical Allied Services Ltd • Updated: 2025-09-17 15:16:56
-
8BusinessHighThe sector is evolving with increasing demand for healthcare services, but the company's competitive advantage is unclear.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are below industry averages, and cash flow is not stable.
-
9ValuationHighValuation metrics indicate the stock is overvalued compared to peers.
-
6BalanceGoodThe company has a moderate debt level, but liquidity is a concern.
-
7GovernanceHighPromoter holding is decent, but there are some concerns regarding transparency.
-
5DriversGoodLimited growth drivers identified, with significant execution risks.
-
1TechnicalsLowMarket sentiment is weak, with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Risky
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 60/100